Brought to you by 
Humanwell & PuraCap acquire Epic Pharma for $550mm; enter US market
15 Sep 2017
Executive Summary
Humanwell Healthcare (Group) Co. Ltd. and PuraCap Pharmaceutical LLC agreed to acquire privately held Epic Pharma LLC (generics) for $550mm ($521mm for Epic Pharma and $29mm for its subsidiary, Epic RE Holdco).
Deal Industry
- Contract Research, Toxicology Testing-CRO
- Pharmaceuticals
- Services
-
Pharmaceuticals
- Generic Drugs
- Specialty Pharmaceuticals
-
Drug Delivery
- Controlled Release
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Humanwell & PuraCap acquire Epic Pharma for $550mm; enter US market
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice